GNFT Relative Valuation - Genfit SA - Alpha Spread

Genfit SA
NASDAQ:GNFT

Watchlist Manager
Genfit SA Logo
Genfit SA
NASDAQ:GNFT
Watchlist
Price: 4.365 USD 0.57% Market Closed
Market Cap: 218.3m USD
Have any thoughts about
Genfit SA?
Write Note

Relative Value

The Relative Value of one GNFT stock under the Base Case scenario is 5.596 USD. Compared to the current market price of 4.365 USD, Genfit SA is Undervalued by 22%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GNFT Relative Value
Base Case
5.596 USD
Undervaluation 22%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
53
vs Industry
63
Median 3Y
4.9
Median 5Y
5.4
Industry
7.7
Forward
2.1
vs History
vs Industry
Median 3Y
-4.5
Median 5Y
-4.2
Industry
23.9
Forward
11.9
vs History
vs Industry
Median 3Y
-2.7
Median 5Y
-2.8
Industry
22.2
vs History
vs Industry
Median 3Y
-2.6
Median 5Y
-2.7
Industry
24
vs History
38
vs Industry
32
Median 3Y
2.1
Median 5Y
2.4
Industry
2.5
vs History
42
vs Industry
54
Median 3Y
4
Median 5Y
4.3
Industry
7.4
Forward
1.9
vs History
44
vs Industry
53
Median 3Y
4.3
Median 5Y
4.6
Industry
8.5
vs History
vs Industry
Median 3Y
-3.6
Median 5Y
-3.2
Industry
5.1
Forward
18.9
vs History
vs Industry
Median 3Y
-3.4
Median 5Y
-3
Industry
4.7
Forward
9.3
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-1.9
Industry
6.6
vs History
vs Industry
Median 3Y
-1.7
Median 5Y
-1.9
Industry
4.7
vs History
58
vs Industry
46
Median 3Y
1.9
Median 5Y
4
Industry
4.7

Multiples Across Competitors

GNFT Competitors Multiples
Genfit SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Genfit SA
NASDAQ:GNFT
217.5m USD 5.1 -6.8 -7.2 -6.8
US
Abbvie Inc
NYSE:ABBV
341.5B USD 6.2 64.5 15.7 24.1
US
Amgen Inc
NASDAQ:AMGN
180.5B USD 5.8 57.7 20.2 36.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
129B USD 9.6 29.8 26.2 29
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
123.6B USD 12 -252.2 26.8 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
105B USD 3.8 99.7 9.5 12
US
Epizyme Inc
F:EPE
94.1B EUR 1 975 -504 -548.8 -534.2
AU
CSL Ltd
ASX:CSL
142.3B AUD 6.5 36.4 22.3 27.8
US
Seagen Inc
F:SGT
39.3B EUR 19 -58.3 -62.8 -56.7
US
Palatin Technologies Inc
LSE:0KF3
38.5B USD 6 513.5 -1 169.6 -1 185.3 -1 173.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
35.2B USD 15 -483 212.6 327.3
P/E Multiple
Earnings Growth
FR
Genfit SA
NASDAQ:GNFT
Average P/E: 57.6
Negative Multiple: -6.8
N/A
US
Abbvie Inc
NYSE:ABBV
64.5
406%
US
Amgen Inc
NASDAQ:AMGN
57.7
74%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29.8
56%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -252.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
99.7
71%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -504 N/A
AU
CSL Ltd
ASX:CSL
36.4
64%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.3 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 169.6 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -483 N/A
EV/EBITDA Multiple
EBITDA Growth
FR
Genfit SA
NASDAQ:GNFT
Average EV/EBITDA: 47.6
Negative Multiple: -7.2
N/A
US
Abbvie Inc
NYSE:ABBV
15.7
28%
US
Amgen Inc
NASDAQ:AMGN
20.2
57%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
26.2
47%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.8
39%
US
Gilead Sciences Inc
NASDAQ:GILD
9.5
10%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -548.8 N/A
AU
CSL Ltd
ASX:CSL
22.3
45%
US
S
Seagen Inc
F:SGT
Negative Multiple: -62.8 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 185.3 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
212.6
N/A
EV/EBIT Multiple
EBIT Growth
FR
Genfit SA
NASDAQ:GNFT
Average EV/EBIT: 69.3
Negative Multiple: -6.8
N/A
US
Abbvie Inc
NYSE:ABBV
24.1
86%
US
Amgen Inc
NASDAQ:AMGN
36.6
95%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
29
49%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
12
26%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -534.2 N/A
AU
CSL Ltd
ASX:CSL
27.8
59%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.7 N/A
US
P
Palatin Technologies Inc
LSE:0KF3
Negative Multiple: -1 173.1 N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
327.3
N/A

See Also

Discover More
Back to Top